Latest News
Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals Incorporated Estimates – OTC:LGNZZ
- Price to sales forward of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ
- Ligand Pharmaceuticals plans annual Investor Day after stock ends session down 2.3%
- Ligand to Host Investor Day on December 8, 2026
- Other financing cash flow items (total) of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ
- Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026
- Here's How Much $1000 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today
- Ligand Pharmaceuticals (LGND) Is Getting Fresh Attention, So What Is Behind It?
- Full Transcript: Ligand Pharmaceuticals Q2 2026 Earnings Call
- Barclays rates Ligand Pharmaceuticals 'Overweig...
- Barclays initiates Ligand Pharma stock with overweight rating
- Ligand and AvenCell Therapeutics Enter Financing Agreement
Headlines from the last 30 days, linking to the original publishers. See all market news →